Free Trial

Aviva (LON:AV) Price Target Raised to GBX 735

Aviva logo with Financial Services background

Aviva (LON:AV - Get Free Report) had its price objective increased by JPMorgan Chase & Co. from GBX 695 ($9.33) to GBX 735 ($9.87) in a report released on Wednesday, MarketBeat.com reports. The brokerage currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s target price indicates a potential upside of 15.31% from the company's current price.

Separately, Citigroup assumed coverage on Aviva in a research report on Tuesday. They set a "neutral" rating and a GBX 623 ($8.36) target price on the stock. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Aviva currently has a consensus rating of "Buy" and a consensus target price of GBX 636 ($8.54).

Read Our Latest Stock Report on Aviva

Aviva Stock Performance

Shares of LON AV traded up GBX 2.20 ($0.03) during midday trading on Wednesday, reaching GBX 637.40 ($8.56). The company's stock had a trading volume of 3,299,060 shares. Aviva has a 12-month low of GBX 390.70 ($5.24) and a 12-month high of GBX 510.20 ($6.85). The firm has a 50 day moving average price of GBX 611.49 and a 200-day moving average price of GBX 552.96. The stock has a market capitalization of £17.13 billion, a P/E ratio of 13.14, a PEG ratio of 2.01 and a beta of 0.89. The company has a debt-to-equity ratio of 68.87, a current ratio of 2.93 and a quick ratio of 1.57.

Insider Buying and Selling at Aviva

In other news, insider Ian Clark bought 8,100 shares of the company's stock in a transaction dated Wednesday, July 9th. The stock was bought at an average cost of GBX 617 ($8.28) per share, for a total transaction of £49,977 ($67,083.22). Corporate insiders own 0.17% of the company's stock.

About Aviva

(Get Free Report)

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.

Read More

Analyst Recommendations for Aviva (LON:AV)

Should You Invest $1,000 in Aviva Right Now?

Before you consider Aviva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aviva wasn't on the list.

While Aviva currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines